serine/threonine Kinase 33 (STK33) (N-Term) Peptide
STK33
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all STK33 products
- STK33 (serine/threonine Kinase 33 (STK33))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VPPVLVVEMS QTSSIGSAES LISLERKKEK NINRDITSRK DLPSRTSNVE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-STK33 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- STK33 (serine/threonine Kinase 33 (STK33))
- Synonyms
- 4921505G21Rik Peptide, AW061264 Peptide, serine/threonine kinase 33 Peptide, STK33 Peptide, Stk33 Peptide
- Background
-
STK33 is a serine/threonine protein kinase which phosphorylates VIME. STK33 may play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME By similarity. STK33 is not essential for the survival of KRAS-dependent AML cell lines.
Alias Symbols: -
Protein Size: 514 - Molecular Weight
- 58 kDa
- Gene ID
- 65975
- NCBI Accession
- NM_030906, NP_112168
- UniProt
- Q9BYT3
-
You are here:
